ESD

S-formylglutathione hydrolase · P10768 · ESD on Sugi Atlas →

50 patent compounds predicted against ESD, 32 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL27997401 SCHEMBL27997401 1.00 1/20
SCHEMBL6292699 SCHEMBL6292699 0.75 1/20
SCHEMBL27997620 SCHEMBL27997620 0.65 1/20
SCHEMBL6294300 SCHEMBL6294300 0.63 1/20
SCHEMBL27997398 SCHEMBL27997398 0.61 1/20
SCHEMBL6298090 SCHEMBL6298090 0.61 1/20
SCHEMBL6298319 SCHEMBL6298319 0.60 1/20
SCHEMBL6298325 SCHEMBL6298325 0.60 1/20
SCHEMBL6294160 SCHEMBL6294160 0.58 1/20
SCHEMBL4942223 SCHEMBL4942223 0.55 1/20
SCHEMBL22795865 SCHEMBL22795865 0.55 1/20
SCHEMBL19866240 SCHEMBL19866240 0.53 1/20
SCHEMBL10855110 SCHEMBL10855110 0.53 1/20
SCHEMBL22796281 SCHEMBL22796281 0.53 1/20
SCHEMBL7586677 SCHEMBL7586677 0.53 1/20
SCHEMBL16740643 SCHEMBL16740643 0.53 1/20
SCHEMBL6294124 SCHEMBL6294124 0.52 1/20
SCHEMBL6293086 SCHEMBL6293086 0.51 1/20
SCHEMBL16740653 SCHEMBL16740653 0.50 1/20
SCHEMBL16740631 SCHEMBL16740631 0.48 1/20

Clinical trials — most relevant to ESD by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment PHASE4RECRUITING
Randomized Controlled Trial of Silymarin in Asthma PHASE2/PHASE3WITHDRAWN
Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine PHASE2/PHASE3UNKNOWN
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) PHASE1/PHASE2RECRUITING
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects PHASE1COMPLETED
A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC) PHASE1UNKNOWN
A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure PHASE1COMPLETED
GSNOR Phenotyping/GSNO Challenge in Severe Asthma EARLY_PHASE1COMPLETED
Genetic Variants and Regulation of Specialized Pro-resolving Mediator nanRECRUITING
Gene-by-Smoking Interactions and Risk of Atherosclerosis - Ancillary to ARIC nanCOMPLETED
Prospective Collection of Endoscopic and Histopathologic Data from Endoscopic Procedures Performed in UZ Gent nanRECRUITING
Genetic and Environmental Risk Factors Related to Esophageal Cancer nanACTIVE_NOT_RECRUITING
EDN and Eosinophilic Esophagitis nanRECRUITING
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer nanUNKNOWN
Impact of Hybrid-ESD+ and LiftUp® on the en Bloc/R0 Rate in Colorectal Adenomas Between 2 and 3 cm nanWITHDRAWN
EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish) nanUNKNOWN
Expression of TET1 Gene in Acute Leukaemia nanUNKNOWN
Endoscopic Submucosal Dissection (ESD) nanRECRUITING
Effects of Green Tea Extract (GTE) on Systemic Oxidative and Antioxidative Status in Chinese Patients With Stable Asthma nanCOMPLETED
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
Esophageal String Test in Eosinophilic Esophagitis nanACTIVE_NOT_RECRUITING
Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway nanNOT_YET_RECRUITING
Exploration and Verification of DNA Methylolation in Early Screening of Esophageal Cancer nanUNKNOWN
Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit nanACTIVE_NOT_RECRUITING
Circumferential Submucosal Incision Endoscopic Mucosal Resection Versus Conventional Endoscopic Mucosal Resection of Colonic Polyps nanWITHDRAWN
Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease nanRECRUITING
An Endoscopic Barbed-clips Suturing for Colorectal ESD nanUNKNOWN
Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function nanCOMPLETED
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Effect of Mepolizumab on Severe Eosinophilic Asthma nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a ESD binder may also engage these)

ProteinNameSimilarity
Q9GJT2 1.000 Q9GJT2 →
Q08E20 1.000 Q08E20 →
B0BNE5 1.000 B0BNE5 →
Q9R0P3 0.998 Q9R0P3 →
Q8LAS8 0.993 Q8LAS8 →
A7ZNX7 0.993 A7ZNX7 →
B1J086 0.992 B1J086 →
B1IYB5 0.992 B1IYB5 →
A1A834 0.991 A1A834 →
P51025 0.991 P51025 →
P33018 0.991 P33018 →
Q3Z551 0.991 Q3Z551 →
Q8FFU3 0.991 Q8FFU3 →
Q0TKS8 0.990 Q0TKS8 →
Q1RFI8 0.990 Q1RFI8 →
Q8FKG2 0.990 Q8FKG2 →
Q8X635 0.990 Q8X635 →
A1AD14 0.990 A1AD14 →
Q8X5J5 0.989 Q8X5J5 →
Q1R9R8 0.989 Q1R9R8 →
Q31YW2 0.989 Q31YW2 →
B1LKQ1 0.989 B1LKQ1 →
Q0TFT6 0.988 Q0TFT6 →
B1X7P2 0.988 B1X7P2 →
A8A215 0.988 A8A215 →
A1AXZ2 0.988 A1AXZ2 →
Q3Z052 0.987 Q3Z052 →
Q0T2X0 0.987 Q0T2X0 →
A7ZX03 0.986 A7ZX03 →
B1XEU8 0.986 B1XEU8 →